This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-2491v1 69/4/1293    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slomiany, M. G. Articles by Toole, B. P. Search for Related Content PubMed PubMed Citation Articles by Slomiany, M. G. Articles by Toole, B. P.

Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells

Departments of ¹ Cell Biology and Anatomy, ² Pediatrics and Neurosciences, and ³ Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina

Requests for reprints: Mark Slomiany, Department of Cell Biology and Anatomy, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425. E-mail: slomiamg{at}musc.edu.

Key Words: hyaluronan • CD44 • emmprin • basigin • lactate • monocarboxylate transporters

Interactions of hyaluronan with CD44 in tumor cells play important cooperative roles in various aspects of malignancy and drug resistance. Emmprin (CD147; basigin) is a cell surface glycoprotein of the immunoglobulin superfamily that is highly up-regulated in malignant cancer cells and stimulates hyaluronan production, as well as several downstream signaling pathways. Emmprin also interacts with various monocarboxylate transporters (MCT). Malignant cancer cells use the glycolytic pathway and require MCTs to efflux lactate that results from glycolysis. Glycolysis and lactate secretion contribute to malignant cell behaviors and drug resistance in tumor cells. In the present study, we find that perturbation of endogenous hyaluronan, using small hyaluronan oligosaccharides, rapidly inhibits lactate efflux from breast carcinoma cells; down-regulation of emmprin, using emmprin small interfering RNA, also results in decreased efflux. In addition, we find that CD44 coimmunoprecipitates with MCT1, MCT4, and emmprin and colocalizes with these proteins at the plasma membrane. Moreover, after treatment of the cells with hyaluronan oligosaccharides, CD44, MCT1, and MCT4 become localized intracellularly whereas emmprin remains at the cell membrane. Together, these data indicate that constitutive interactions among hyaluronan, CD44, and emmprin contribute to regulation of MCT localization and function in the plasma membrane of breast carcinoma cells. [Cancer Res 2009;69(4):1293–301]

This article has been cited by other articles:

				B. P. Toole Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities Clin. Cancer Res., December 15, 2009; 15(24): 7462 - 7468. [Abstract] [Full Text] [PDF]

				M. G. Slomiany, L. Dai, L. B. Tolliver, G. D. Grass, Y. Zeng, and B. P. Toole Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides Clin. Cancer Res., December 15, 2009; 15(24): 7593 - 7601. [Abstract] [Full Text] [PDF]

				T. Harris, G. Eliyahu, L. Frydman, and H. Degani Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells PNAS, October 27, 2009; 106(43): 18131 - 18136. [Abstract] [Full Text] [PDF]

				M. G. Slomiany, L. Dai, P. A. Bomar, T. J. Knackstedt, D. A. Kranc, L. Tolliver, B. L. Maria, and B. P. Toole Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides Cancer Res., June 15, 2009; 69(12): 4992 - 4998. [Abstract] [Full Text] [PDF]